Bio-Rad Laboratories Market Cap 2006-2020 | BIO

Bio-Rad Laboratories market cap history and chart from 2006 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Bio-Rad Laboratories market cap as of July 02, 2020 is $13.59B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $13.589B $2.312B
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $163.141B 28.29
Medtronic (MDT) Ireland $124.955B 20.30
Stryker (SYK) United States $68.946B 22.38
Boston Scientific (BSX) United States $49.509B 23.28
Baxter (BAX) United States $44.233B 27.00
Lonza Group Ag (LZAGY) Switzerland $39.871B 0.00
Terumo (TRUMY) Japan $29.963B 38.30
EssilorLuxottica Societe Anonyme (ESLOY) France $28.693B 0.00
ResMed (RMD) United States $27.846B 43.94
Zimmer Biomet Holdings (ZBH) United States $24.894B 15.66
Smith & Nephew SNATS (SNN) United Kingdom $17.257B 0.00
Sunny Optical Technology (SNPTF) China $16.924B 0.00
Insulet (PODD) United States $12.687B 1256.94
DiaSorin S.p.A (DSRLF) Italy $10.994B 0.00
Quidel (QDEL) United States $9.535B 74.93
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
Perrigo (PRGO) Ireland $7.523B 13.46
Hill-Rom Holdings (HRC) United States $7.426B 20.93
GN STORE NORD (GNNDY) Denmark $6.972B 35.54
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $5.771B 0.00
Haemonetics (HAE) United States $4.656B 27.96
Neogen (NEOG) United States $4.108B 69.58
GW Pharmaceuticals (GWPH) United Kingdom $3.892B 0.00
ICU Medical (ICUI) United States $3.890B 28.38
Agios Pharmaceuticals (AGIO) United States $3.836B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.805B 0.00
Envista Holdings (NVST) United States $3.407B 0.00
NuVasive (NUVA) United States $2.925B 23.49
National Vision Holdings (EYE) United States $2.458B 42.53
TG Therapeutics (TGTX) United States $2.213B 0.00
AtriCure (ATRC) United States $1.855B 0.00
MacroGenics (MGNX) United States $1.450B 0.00
Aurora Cannabis (ACB) Canada $1.390B 0.00
NanoString Technologies (NSTG) United States $1.322B 0.00
Aphria (APHA) Canada $1.231B 0.00
Cardiovascular Systems (CSII) United States $1.137B 0.00
Cerus (CERS) United States $1.109B 0.00
Phibro Animal Health (PAHC) United States $1.055B 21.02
Meridian Bioscience (VIVO) United States $1.019B 38.37
PetIQ (PETQ) United States $1.017B 29.37
DFB Healthcare Acquisitions (AHCO) United States $0.924B 153.85
InMode (INMD) Israel $0.897B 18.97
Vapotherm (VAPO) United States $0.881B 0.00
Zynex (ZYXI) United States $0.834B 83.73
Omeros (OMER) United States $0.826B 0.00
Quanterix (QTRX) United States $0.789B 0.00
OraSure Technologies (OSUR) United States $0.746B 150.25
Eagle Pharmaceuticals (EGRX) United States $0.663B 47.51
Surmodics (SRDX) United States $0.585B 70.49
VAREX IMAGING (VREX) United States $0.584B 14.51
Lantheus Holdings (LNTH) United States $0.579B 11.65
LeMaitre Vascular (LMAT) United States $0.532B 30.29
BioLife Solutions (BLFS) United States $0.467B 163.46
Owens & Minor (OMI) United States $0.464B 12.27
Repro-Med Systems (KRMD) United States $0.394B 302.33
Viemed Healthcare (VMD) United States $0.367B 32.55
Cytosorbents (CTSO) United States $0.361B 0.00
Utah Medical Products (UTMD) United States $0.315B 22.85
HEXO (HEXO) $0.311B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.304B 0.00
Organigram Holdings (OGI) Canada $0.285B 0.00
Female Health (VERU) United States $0.229B 0.00
InfuSystems Holdings (INFU) United States $0.213B 117.89
Chimerix (CMRX) United States $0.196B 0.00
Bovie Medical (APYX) United States $0.185B 0.00
Evolus (EOLS) United States $0.185B 0.00
Surface Oncology (SURF) United States $0.178B 0.00
Exagen (XGN) United States $0.161B 0.00
Fonar (FONR) United States $0.135B 11.94
Rockwell Medical (RMTI) United States $0.133B 0.00
United Health Products (UEEC) United States $0.131B 0.00
Liberty Health Sciences (LHSIF) Canada $0.120B 0.00
Wound Management Technologies (SMTI) United States $0.112B 0.00
MTech Acquisition (KERN) United States $0.109B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.084B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.082B 0.00
Nephros (NEPH) United States $0.073B 0.00
United-Guardian (UG) United States $0.071B 16.51
Capricor Therapeutics (CAPR) United States $0.065B 0.00
Brainsway (BWAY) Israel $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.055B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.012B 0.00
Myomo (MYO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00